Clobikem-Gm Neo Cream
By Clobikem-Gm Neo
Rx
10gm Cream in a Tube

Composition
Clobetasol(0.05% w/w) + Neomycin(0.5% w/w) + Miconazole(2% w/w) + Chlorocresol(0.1% w/w)

Manufacturer - Alkem Laboratories Ltd
Alkem Laboratories Limited, Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel, Mumbai - 400 013.

Expires on or after
February, 2027

liver
When it comes to the safety of using Clobikem-Gm Neo Cream in relation to liver health, there is no known interaction or established risk associated with liver issues. This means that there are no specific cautions or concerns regarding the use of Clobikem-Gm Neo Cream in relation to liver function. It is always advisable to consult with your healthcare provider for personalized guidance and to address any specific concerns related to your liver health before using Clobikem-Gm Neo Cream.

kidney
Consult with your doctor for proper guidance before using Clobikem-Gm Neo Cream. It is important to seek advice from a healthcare professional regarding kidney precautions when using this product.

alcohol
No interaction has been found between alcohol and Clobikem-Gm Neo Cream. Pregnant individuals should use caution.

driving
When using Clobikem-Gm Neo Cream, no interactions affecting driving have been found or established. It is safe to drive while using this medication.

pregnancy
**Safety Advice - Pregnancy** Clobikem-Gm Neo Cream may not be safe to use during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will carefully consider the risks and benefits before prescribing this medication. It is advisable to consult your doctor regarding the use of Clobikem-Gm Neo Cream during pregnancy.

breastfeeding
It is better to consult your doctor before using Clobikem-Gm Neo Cream.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | DERMA |
Action Class | - |
₹78
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025